NordicRWE is a R&D focused and technology-driven company that aims to deliver solutions and services that support data-driven drug development. Our own R&D project focuses on two innovative applications of RWE in drug development, namely external control arms for cancer clinical trials, and drug signal detection. Our technology-driven projects focus on interactive dashboard solutions, and synthetic data generation.
A wave of new personalized treatments for cancer have been introduced in recent years, mainly based on RCTs with novel biomarkers/mutations to guide specific targeted therapies. With this research project we aim to emulate populations, and reproduce outcomes from cancer clinical trials.
Read more about External control arms
With this research project we propose a novel, data-driven alternative for drug discovery and drug surveillance that combines machine learning hypothesis generation with subsequent rigorous pharmacoepidemiological hypothesis validation using longitudinal real-world data (RWD).
Read more about Drug signal detection
Alongside our ongoing R&D, we actively pursue new technologies that can drive progress and increase customer value in various fields of Real-world Evidence studies. Currently, our technology development focuses on delivering interactive dashboard solutions for studies, and utilization of synthetic data.
Read more about Technology developmentExternal control arm and clinical trial contextualization of a neoantigen-based therapeutic cancer vaccine for an international biotech company
Disease epidemiology, treatment patterns and real-world outcomes for common chronic disease for a Nordic pharma affiliate
Target trial emulation study in the field of oncology to support access and launch for a global pharma company
